These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 10746673)

  • 21. Lynch syndrome--related endometrial carcinomas show a high frequency of nonendometrioid types and of high FIGO grade endometrioid types.
    Carcangiu ML; Radice P; Casalini P; Bertario L; Merola M; Sala P
    Int J Surg Pathol; 2010 Feb; 18(1):21-6. PubMed ID: 19443869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PTEN as a molecular marker to distinguish metastatic from primary synchronous endometrioid carcinomas of the ovary and uterus.
    Ricci R; Komminoth P; Bannwart F; Torhorst J; Wight E; Heitz PU; Caduff RF
    Diagn Mol Pathol; 2003 Jun; 12(2):71-8. PubMed ID: 12766611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TP53 mutations in endometrial cancers: relation to PTEN gene defects.
    Janiec-Jankowska A; Konopka B; Goluda C; Najmoła U
    Int J Gynecol Cancer; 2010 Feb; 20(2):196-202. PubMed ID: 20169661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of mammalian target of rapamycin with aggressive type II endometrial carcinomas and poor outcome: a potential target treatment.
    Peiró G; Peiró FM; Ortiz-Martínez F; Planelles M; Sánchez-Tejada L; Alenda C; Ceballos S; Sánchez-Payá J; Laforga JB
    Hum Pathol; 2013 Feb; 44(2):218-25. PubMed ID: 22955108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High concordance of molecular tumor alterations between pre-operative curettage and hysterectomy specimens in patients with endometrial carcinoma.
    Stelloo E; Nout RA; Naves LC; Ter Haar NT; Creutzberg CL; Smit VT; Bosse T
    Gynecol Oncol; 2014 May; 133(2):197-204. PubMed ID: 24556061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct sets of gene alterations in endometrial carcinoma implicate alternate modes of tumorigenesis.
    Koul A; Willén R; Bendahl PO; Nilbert M; Borg A
    Cancer; 2002 May; 94(9):2369-79. PubMed ID: 12015762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular pathology of endometrial hyperplasia and carcinoma.
    Matias-Guiu X; Catasus L; Bussaglia E; Lagarda H; Garcia A; Pons C; Muñoz J; Argüelles R; Machin P; Prat J
    Hum Pathol; 2001 Jun; 32(6):569-77. PubMed ID: 11431710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular genetic characterization of tamoxifen-associated endometrial cancer.
    Prasad M; Wang H; Douglas W; Barakat RR; Ellenson LH
    Gynecol Oncol; 2005 Jan; 96(1):25-31. PubMed ID: 15589576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors.
    Obata K; Morland SJ; Watson RH; Hitchcock A; Chenevix-Trench G; Thomas EJ; Campbell IG
    Cancer Res; 1998 May; 58(10):2095-7. PubMed ID: 9605750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Common genetic changes between endometriosis and ovarian cancer.
    Obata K; Hoshiai H
    Gynecol Obstet Invest; 2000; 50 Suppl 1():39-43. PubMed ID: 11093060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PTEN mutation located only outside exons 5, 6, and 7 is an independent predictor of favorable survival in endometrial carcinomas.
    Minaguchi T; Yoshikawa H; Oda K; Ishino T; Yasugi T; Onda T; Nakagawa S; Matsumoto K; Kawana K; Taketani Y
    Clin Cancer Res; 2001 Sep; 7(9):2636-42. PubMed ID: 11555573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alteration of PTEN expression in endometrial carcinoma is associated with down-regulation of cyclin-dependent kinase inhibitor, p27.
    An HJ; Lee YH; Cho NH; Shim JY; Kim JY; Lee C; Kim SJ
    Histopathology; 2002 Nov; 41(5):437-45. PubMed ID: 12405911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Racial disparity in the frequency of PTEN mutations, but not microsatellite instability, in advanced endometrial cancers.
    Maxwell GL; Risinger JI; Hayes KA; Alvarez AA; Dodge RK; Barrett JC; Berchuck A
    Clin Cancer Res; 2000 Aug; 6(8):2999-3005. PubMed ID: 10955777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microsatellite instability and mutation analysis of candidate genes in unselected sardinian patients with endometrial carcinoma.
    Baldinu P; Cossu A; Manca A; Satta MP; Pisano M; Casula M; Dessole S; Pintus A; Tanda F; Palmieri G
    Cancer; 2002 Jun; 94(12):3157-68. PubMed ID: 12115348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frameshift mutations at coding mononucleotide repeat microsatellites in endometrial carcinoma with microsatellite instability.
    Catasus L; Matias-Guiu X; Machin P; Zannoni GF; Scambia G; Benedetti-Panici P; Prat J
    Cancer; 2000 May; 88(10):2290-7. PubMed ID: 10820351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microsatellite instability in endometrial carcinomas: clinicopathologic correlations in a series of 42 cases.
    Catasus L; Machin P; Matias-Guiu X; Prat J
    Hum Pathol; 1998 Oct; 29(10):1160-4. PubMed ID: 9781658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [An approach to early genetic alterations in precancerous cells].
    Sato N; Nishida M; Noguchi M
    Hum Cell; 2000 Sep; 13(3):103-8. PubMed ID: 11197771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutations in the BRCA1-associated RING domain (BARD1) gene in primary breast, ovarian and uterine cancers.
    Thai TH; Du F; Tsan JT; Jin Y; Phung A; Spillman MA; Massa HF; Muller CY; Ashfaq R; Mathis JM; Miller DS; Trask BJ; Baer R; Bowcock AM
    Hum Mol Genet; 1998 Feb; 7(2):195-202. PubMed ID: 9425226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutation profile and clinical outcome of mixed endometrioid-serous endometrial carcinomas are different from that of pure endometrioid or serous carcinomas.
    Coenegrachts L; Garcia-Dios DA; Depreeuw J; Santacana M; Gatius S; Zikan M; Moerman P; Verbist L; Lambrechts D; Matias-Guiu X; Amant F
    Virchows Arch; 2015 Apr; 466(4):415-22. PubMed ID: 25677978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RAS/RAF mutation and defective DNA mismatch repair in endometrial cancers.
    Mutch DG; Powell MA; Mallon MA; Goodfellow PJ
    Am J Obstet Gynecol; 2004 Apr; 190(4):935-42. PubMed ID: 15118616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.